GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 91 filers reported holding GENERATION BIO CO in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $604,642 | -33.9% | 159,536 | -4.1% | 0.00% | – |
Q2 2023 | $915,206 | +31.9% | 166,401 | +3.1% | 0.00% | – |
Q1 2023 | $693,861 | +7.7% | 161,363 | -1.6% | 0.00% | – |
Q4 2022 | $644,241 | -26.6% | 163,929 | -0.9% | 0.00% | – |
Q3 2022 | $878,000 | -8.3% | 165,415 | +13.3% | 0.00% | – |
Q2 2022 | $957,000 | -9.0% | 145,941 | +1.8% | 0.00% | – |
Q1 2022 | $1,052,000 | -75.6% | 143,405 | -76.4% | 0.00% | -100.0% |
Q4 2021 | $4,307,000 | -73.2% | 608,299 | -5.2% | 0.00% | -66.7% |
Q3 2021 | $16,092,000 | -3.8% | 641,857 | +3.2% | 0.00% | 0.0% |
Q2 2021 | $16,735,000 | +3.6% | 622,073 | +9.6% | 0.00% | 0.0% |
Q1 2021 | $16,154,000 | +93.7% | 567,594 | +93.0% | 0.00% | +50.0% |
Q4 2020 | $8,339,000 | -7.4% | 294,162 | +1.0% | 0.00% | 0.0% |
Q3 2020 | $9,005,000 | +1318.1% | 291,329 | +863.1% | 0.00% | – |
Q2 2020 | $635,000 | – | 30,248 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
Corton Capital Inc. | 15,493 | $102,000 | 0.10% |